| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Regina Katzenschlager, Durval Costa, Willibald Gerschlager, John O'Sullivan, Jan Zijlmans, Svetoslav Gacinovic, Walter Pirker, Adrian Wills, Kailash Bhatia, Andrew J Lees, Peter Brow. [123I]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. Annals of neurology. vol 53. issue 4. 2003-04-28. PMID:12666116. |
our finding of a marked tracer uptake reduction on dopamine transporter spect supports a role of the dopaminergic system in ot. |
2003-04-28 |
2023-08-12 |
Not clear |
| A H V Schapir. Dopamine agonists and neuroprotection in Parkinson's disease. European journal of neurology. vol 9 Suppl 3. 2003-04-23. PMID:12464116. |
numerous studies have demonstrated that a variety of dopamine agonists can protect dopaminergic neuronal function in several toxin model systems. |
2003-04-23 |
2023-08-12 |
Not clear |
| Katerina Tumova, Rafal M Iwasiow, Mario Tiber. Insight into the mechanism of dopamine D1-like receptor activation. Evidence for a molecular interplay between the third extracellular loop and the cytoplasmic tail. The Journal of biological chemistry. vol 278. issue 10. 2003-04-23. PMID:12509438. |
a chimeric d1a dopaminergic receptor harboring the cytoplasmic tail (ct) of the d1b subtype (d1a-ctb) has been used previously to show that ct imparts high dopamine (da) affinity and constitutive activity to the d1b receptors. |
2003-04-23 |
2023-08-12 |
human |
| Jennifer L Tillerson, Gary W Mille. Grid performance test to measure behavioral impairment in the MPTP-treated-mouse model of parkinsonism. Journal of neuroscience methods. vol 123. issue 2. 2003-04-23. PMID:12606067. |
behavioral impairments in mice following administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp) require large depletions in striatal dopamine content and are often transient. |
2003-04-23 |
2023-08-12 |
mouse |
| Michael T Sellix, Marc E Freema. Circadian rhythms of neuroendocrine dopaminergic neuronal activity in ovariectomized rats. Neuroendocrinology. vol 77. issue 1. 2003-04-23. PMID:12624542. |
prolactin (prl) secretion is inhibited by dopamine (da) released from hypothalamic neuroendocrine neurons designated tuberoinfundibular (tida), tuberohypophyseal (thda) and periventricular hypophyseal (phda) dopaminergic (daergic) neurons. |
2003-04-23 |
2023-08-12 |
rat |
| Philip Gorwood, Frédéric Limosin, Philippe Batel, Michel Hamon, Jean Adès, Claudette Bon. The A9 allele of the dopamine transporter gene is associated with delirium tremens and alcohol-withdrawal seizure. Biological psychiatry. vol 53. issue 1. 2003-04-22. PMID:12513948. |
the dopamine transporter (dat) plays a key role in homeostatic regulation of dopaminergic neurotransmission and could thus be involved in the variability of two severe alcohol-withdrawal symptoms, alcohol-withdrawal seizure (aws) and delirium tremens (dt). |
2003-04-22 |
2023-08-12 |
Not clear |
| Tatiana Ivanova, Cordian Beye. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. Journal of neurobiology. vol 54. issue 4. 2003-04-22. PMID:12555275. |
taken together, our data strongly suggest that estrogen controls dopamine synthesis in the developing nigrostriatal dopaminergic system and support the concept that estrogen is implicated in the regulation of ontogenetic steps but also in the function of midbrain dopamine neurons. |
2003-04-22 |
2023-08-12 |
mouse |
| Jan Booij, Kora de Bruin, Jan B A Habraken, Pieter Voor. Imaging of dopamine transporters in rats using high-resolution pinhole single-photon emission tomography. European journal of nuclear medicine and molecular imaging. vol 29. issue 9. 2003-04-17. PMID:12418461. |
dopamine transporter imaging is a valuable non-invasive tool with which to investigate the integrity of dopaminergic neurons. |
2003-04-17 |
2023-08-12 |
rat |
| Fu-Ming Zhou, Charles Wilson, John A Dan. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry. vol 9. issue 1. 2003-04-16. PMID:12580337. |
the striatum and its dense dopaminergic innervation originating in the midbrain, primarily from the substantia nigra pars compacta and the ventral tegmental area, compose the mesostriatal dopamine (da) systems. |
2003-04-16 |
2023-08-12 |
Not clear |
| R Bettini, M Gorin. [Effectiveness and tolerability of selegiline in the treatment of pathological cerebral involutions]. La Clinica terapeutica. vol 153. issue 6. 2003-04-14. PMID:12645393. |
a dysfunction of dopaminergic systems with reduction of active dopamine, is well-known in cerebral involution. |
2003-04-14 |
2023-08-12 |
Not clear |
| V Sossi, J E Holden, R de la Fuente-Fernandez, T J Ruth, A J Stoess. Effect of dopamine loss and the metabolite 3-O-methyl-[18F]fluoro-dopa on the relation between the 18F-fluorodopa tissue input uptake rate constant Kocc and the [18F]fluorodopa plasma input uptake rate constant Ki. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. vol 23. issue 3. 2003-04-08. PMID:12621305. |
parkinson disease is characterized by the loss of dopaminergic neurons, thus decreasing the system's ability to produce and store dopamine (da). |
2003-04-08 |
2023-08-12 |
Not clear |
| B Florán, C Barajas, L Florán, D Erlij, J Aceve. Adenosine A1 receptors control dopamine D1-dependent [(3)H]GABA release in slices of substantia nigra pars reticulata and motor behavior in the rat. Neuroscience. vol 115. issue 3. 2003-04-07. PMID:12435413. |
adenosine appears to modulate the dopaminergic control in striatum, where an inhibitory interaction between adenosine and dopamine receptors has been demonstrated. |
2003-04-07 |
2023-08-12 |
rat |
| James D Foster, Benchaporn Pananusorn, Mark A Cervinski, Heather E Holden, Roxanne A Vaugha. Dopamine transporters are dephosphorylated in striatal homogenates and in vitro by protein phosphatase 1. Brain research. Molecular brain research. vol 110. issue 1. 2003-04-04. PMID:12573538. |
phosphorylation conditions also lead to reductions in dopamine transport activity, which may function to regulate synaptic dopamine levels and control the extent and duration of dopaminergic signaling. |
2003-04-04 |
2023-08-12 |
rat |
| Lee A Dawson, Huy Q Nguyen, Ping L. Potentiation of amphetamine-induced changes in dopamine and 5-HT by a 5-HT(6) receptor antagonist. Brain research bulletin. vol 59. issue 6. 2003-04-04. PMID:12576149. |
although recent data has shown that 5-ht(6) receptor antagonists' can enhance basal cholinergic and glutamatergic neurotransmission in the cortex and hippocampus, the distribution of this receptor within terminal regions of the dopaminergic system suggests a possible role for this receptor in the modulation of dopamine (da). |
2003-04-04 |
2023-08-12 |
rat |
| Hiroyuki Suganuma, Takaaki Hirano, Yasushi Arimoto, Takahiro Inakum. Effect of tomato intake on striatal monoamine level in a mouse model of experimental Parkinson's disease. Journal of nutritional science and vitaminology. vol 48. issue 3. 2003-04-03. PMID:12350086. |
to assess the preventive effect of tomato against the mptp-induced selective destruction of dopaminergic nigrostrie, we determined striatal dopamine (da). |
2003-04-03 |
2023-08-12 |
mouse |
| J Taylor Hays, Jon O Ebber. Bupropion for the treatment of tobacco dependence: guidelines for balancing risks and benefits. CNS drugs. vol 17. issue 2. 2003-03-31. PMID:12521356. |
the efficacy of bupropion for the treatment of tobacco dependence is attributed to the blockage of dopamine reuptake in the mesolimbic dopaminergic system. |
2003-03-31 |
2023-08-12 |
Not clear |
| A Antonini, R M Moresco, C Gobbo, R De Notaris, A Panzacchi, P Barone, V Bonifati, G Pezzoli, F Fazi. Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT: preliminary findings in one patient with autosomal recessive parkinsonism (Park2). Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. vol 23 Suppl 2. 2003-03-28. PMID:12548339. |
neuroimaging studies of striatal dopamine transporters (dat) have shown that this measurement is a specific marker of dopaminergic degeneration in patients with parkinson's disease. |
2003-03-28 |
2023-08-12 |
human |
| Alberto Costa, Antonella Peppe, Grazia Dell'Agnello, Giovanni Augusto Carlesimo, Luigi Murri, Ubaldo Bonuccelli, Carlo Caltagiron. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dementia and geriatric cognitive disorders. vol 15. issue 2. 2003-03-28. PMID:12566593. |
the aim of this study was to evaluate the performance of a group of pd patients in visual-spatial and visual-object wm tasks and to investigate the effect of administering the dopaminergic agonist apomorphine (experiment 1) or the dopamine precursor l-dopa (experiment 2) on the performance of tests assessing these functions. |
2003-03-28 |
2023-08-12 |
Not clear |
| Elio Raviol. A molecular approach to retinal neural networks. Functional neurology. vol 17. issue 3. 2003-03-27. PMID:12549715. |
we have thus demonstrated that the retinal dopaminergic neurons spontaneously generate action potentials in a rhythmic fashion, release dopamine over their entire surface, establish gabaergic synapses and contain proteins whose existence went undetected with more conventional techniques. |
2003-03-27 |
2023-08-12 |
mouse |
| Paola Rocc, Concetta De Leo, Carola Eva, Livio Marchiaro, Anna Maria Milani, Rita Musso, Luigi Ravizza, Enrico Zanalda, Filippo Bogett. Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Progress in neuro-psychopharmacology & biological psychiatry. vol 26. issue 6. 2003-03-26. PMID:12452539. |
a tempting approach to examine alterations of dopaminergic system in major depression is to examine the expression of dopamine receptors in peripheral blood mononuclear cells (pbmc). |
2003-03-26 |
2023-08-12 |
Not clear |